檢索結果 - Brahmer, Julie

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer 由 Ulahannan, Susanna V, Brahmer, Julie R

獲取全文 獲取全文 獲取全文

Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer 由 Brahmer, Julie R., Pardoll, Drew M.

獲取全文 獲取全文 獲取全文

Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer 由 Wills, Beatriz, Brahmer, Julie R., Naidoo, Jarushka

獲取全文 獲取全文 獲取全文

Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer 由 Drake, Charles G., Lipson, Evan J., Brahmer, Julie R.

獲取全文 獲取全文 獲取全文

New Strategies in Lung Cancer: Epigenetic Therapy for Non–Small Cell Lung Cancer 由 Forde, Patrick M., Brahmer, Julie R., Kelly, Ronan J.

獲取全文 獲取全文 獲取全文

Nivolumab in NSCLC: latest evidence and clinical potential 由 Sundar, Raghav, Cho, Byoung-Chul, Brahmer, Julie R., Soo, Ross A.

獲取全文 獲取全文 獲取全文

What Lies Within: Novel Strategies in Immunotherapy for Non-Small Cell Lung Cancer 由 Forde, Patrick M., Reiss, Kim A., Zeidan, Amer M., Brahmer, Julie R.

獲取全文 獲取全文 獲取全文

Immunotherapy in the treatment of non-small cell lung cancer 由 Sundar, Raghav, Soong, Richie, Cho, Byoung-Chul, Brahmer, Julie R., Soo, Ross A.

獲取全文 獲取全文 獲取全文

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer 由 Taunk, Neil K., Rimner, Andreas, Culligan, Melissa, Friedberg, Joseph S., Brahmer, Julie, Chaft, Jamie

獲取全文 獲取全文 獲取全文

The emerging role of epigenetic therapeutics in immuno-oncology 由 Topper, Michael J., Vaz, Michelle, Marrone, Kristen A., Brahmer, Julie R., Baylin, Stephen B.

獲取全文 獲取全文 獲取全文

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4... 由 Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.

獲取全文 獲取全文 獲取全文

Prognostic Models to Predict Survival in Non-Small Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab 由 Hoang, Tien, Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.

獲取全文 獲取全文 獲取全文

Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 350... 由 Amann, Joseph M., Lee, Ju-Whei, Roder, Heinrich, Brahmer, Julie, Gonzalez, Adriana, Schiller, Joan H., Carbone, David P.

獲取全文 獲取全文 獲取全文

Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Treated with or without Bevacizumab in Combination with Pac... 由 Brahmer, Julie R., Dahlberg, Suzanne E., Gray, Robert J., Schiller, Joan H., Perry, Michael C., Sandler, Alan, Johnson, David H.

獲取全文 獲取全文 獲取全文

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer T... 由 Sandler, Alan B., Schiller, Joan H., Gray, Robert, Dimery, Isaiah, Brahmer, Julie, Samant, Meghna, Wang, Lisa I., Johnson, David H.

獲取全文 獲取全文 獲取全文

Body Mass Index and its Association with Clinical Outcomes for Advanced Non-Small Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials 由 Dahlberg, Suzanne E., Schiller, Joan H., Bonomi, Philip B., Sandler, Alan B., Brahmer, Julie R., Ramalingam, Suresh S., Johnson, David H.

獲取全文 獲取全文 獲取全文

Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung canc... 由 Brahmer, Julie, Balmanoukian, Ani, Goldberg, Sarah, Ou, Sai-Hong, Blake-Haskins, Andrew, Karakunnel, Joyson, Stockman, Paul, Rizvi, Naiyer, Antonia, Scott

獲取全文 獲取全文

Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature 由 Zhang, Yuan, Zhang, Sean X., Trivedi, Julie, Toll, Adam D., Brahmer, Julie, Hales, Russell, Bonerigo, Sarah, Zeng, Mingying, Li, Huiping, Yung, Rex C.

獲取全文 獲取全文 獲取全文

Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors 由 Messersmith, Wells A., Jimeno, Antonio, Ettinger, David, Laheru, Dan, Brahmer, Julie, Lansey, Dina, Khan, Yasmin, Donehower, Ross C., Elsayed, Yusri, Zannikos, Peter, Hidalgo, Manuel

獲取全文 獲取全文 獲取全文

Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen 由 Cappelli, Laura C., Brahmer, Julie R., Forde, Patrick M., Le, Dung T., Lipson, Evan J., Naidoo, Jarushka, Zheng, Lei, Bingham, Clifton O., Shah, Ami A.

獲取全文 獲取全文 獲取全文